Error: Could not add to watchlist. X

Summit Therapeutics PLC

+ Watchlist
SUMM:LN
London
149.00
GBp
0.00
0.00%
As of 02:30:15 ET on 09/04/2015.
Open
149.00
Day Range
149.00 - 149.00
Volume
10,287
Previous Close
149.00
52Wk Range
107.00 - 185.00
1 Yr Return
-10.24%
Open
149.00
Day Range
149.00 - 149.00
Volume
10,287
Previous Close
149.00
52Wk Range
107.00 - 185.00
1 Yr Return
-10.24%
YTD Return
9.96%
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-0.26
Market Cap (m GBp)
91.323
Shares Outstanding (m)
61.291
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Summit Therapeutics PLC is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.
ADDRESS
85b Park Drive Milton Park
Abingdon, Oxfordshire
Oxfordshire
United Kingdom
PHONE
44-123-544-3939
  • Glyn O Edwards
    Chief Executive Officer
  • Erik Ostrowski
    Chief Financial Officer
  • Ralf Rosskamp
    Chief Medical Officer
  • Jonathon Tinsley
    Chief Scientific Officer
  • Richard Vickers
    Chief Scientific Ofcr:Antimicrobials
Show More